Qurat-Ul-Ain Kamili, MD
• Completed a combined fellowship in Allergy, Immunology and Rheumatology at Baylor College of Medicine located in the Texas Medical Center at Houston Texas.
• Chief Fellow Allergy, Immunology and Rheumatology (Baylor College of Medicine at Houston, Texas)
• Completed medical school at the University of Kashmir, India followed by a residency in Dermatology at the same institution. Board Certified in Dermatology (Medical Council of India)
• Completed residency in Internal Medicine at Baylor College of Medicine at Houston, Texas. American Board Certified in Internal Medicine.
• American Board Certified In Asthma, Allergy, & Immunology
• American Board Certified In Rheumatology
Education
Baylor College of Medicine–Allergy, Immunology and Rheumatology Fellowship Program, 2012 – 2015
The fellowship program provides diverse training at the Harris Health System; Michael E. DeBakey Veterans Affairs Medical Center; MD Anderson Cancer Center; Texas Childrens Hospital and Baylor Clinic.
Baylor College of Medicine–Doctor of Medicine (MD), Internal Medicine Residency Program
BCM is a principal institution of Houston’s Texas Medical Center, which is world renowned for advances in medical research and patient care.
University of Kashmir–MD, Dermatology, STD and Leprosy
Affiliations: Indian Association of Dermatology, Venereology & Leprology
University of Kashmir–MBBS, Bachelor of Medicine, Bachelor of Surgery
Experience
Physician-Allergy Partners of North Texas/Dallas Allergy Immunology
Fellow-Baylor College of Medicine
Research Fellow-Baylor Research Institute, Baylor Institute for Immunology Research
Translational genomics project evaluating “Immune Markers in psoriasis and other skin disorders”.
– Responsible for designing the project and managing logistics.
– Working in the dermatology clinic identifying and screening study subjects.
– Responsible for clinical assessment, consent and sample collection.
– Processing samples using microarray technology and analyzing gene expression.
– Concurrently involved in clinical research projects, writing peer reviewed and invited journal articles.
– Didactic teaching at Baylor University Medical Center Internal Medicine Residency Program.
Providing Hope for People with Food Allergies
Our innovative food allergy immunotherapy program has helped hundreds of children overcome a fear of food.
Dallas Food Allergy Center (DFAC) is the food allergy specialty practice at Allergy Partners of North Dallas. We are one of the few practices in the country that offer a breakthrough oral immunotherapy program for kids with food allergies. Our treatment provides a long-term solution for wheat, egg, peanut, tree nut, and milk allergic patients. It is usually takes less than 6 months, and at the end of the program, most patients with allergies to wheat, egg, peanut, tree nut, or milk are able to consume these foods with no allergic reaction.
More than 80% of our patients can now safely consume foods that once threatened their health.
The DFAC program has helped hundreds of children by setting them free from fear of their food allergies. The treatment works by introducing minute doses of wheat, egg, peanut or milk in solution for approximately 6 months (time period varies on individual differences). The program then progresses to small doses of the whole food for an additional several months, allowing the patient to eat these foods. As a result, the vast majority of our patients are able to consume wheat, eggs, peanuts and/or milk without any adverse reactions.
What would it mean to your family if you were free from worrying about severe food allergies?
Families tell us we have changed their lives significantly by helping their children eat foods that used to be harmful. The impact on family life has made a difference for not only the allergic child, but also for siblings and parents. Many children have graduated from the DFAC Food OIT program and are now eating eggs, wheat, tree nuts, or peanuts or are drinking milk without reactions.
What to expect from the DFAC food allergy program:
This program is designed for a child of school age or older who will be old enough to understand the reasons for participating and be actively engaged in the process.
The first visit of the oral immunotherapy process is a full day during which the child will receive multiple doses of very small amounts of diluted milk, diluted wheat powder, diluted peanut (or nut) powder, or diluted egg powder. The child will return weekly for dose increases followed by one hour of observation. Between each visit the patient will take two doses of the desensitization (allergenic) food each day at home. Once oral immunotherapy is complete, the previously allergenic food can be freely included in the diet. The food must be eaten daily to maintain the ability to eat it safely.
Want to know about treating your child’s food allergy?
If you are interested in learning more about how your child can be treated for food allergies, please contact our office at 972-566-7788. Most insurance policies cover this treatment. We invite you to call us and find out how we can help your child as well as your whole family live without a fear of food.
Note to Allergists/Immunologists: If you would like to obtain a copy of the oral immunotherapy procedures we use, please send an email request to drrichwasserman@gmail.com
. Include a link to your website or enough identifiers so that I can confirm that you are Certified by the American Board of Allergy and Immunology. After confirmation we will provide you with the information requested.
Contact
Dr. Qurat Kamili
Dallas: 7777 Forest Ln #B332, Dallas, TX 75230
Frisco: 4500 Hillcrest Rd, Frisco, TX 75035
(972) 566-7788
http://dallasallergy.net
DallasAllergyImmunology / Allergy Partners of North Texas: Dr. Richard Wasserman, Dr. Robert Sugerman, Dr. Stacy Silvers, Dr. Qurat Kamili
OIT Details
State: Texas
Treats single/multi allergens at once: Both options: have done up to 4 nuts and would be open to other combinations.
Offers SLIT for food allergens: No
Additional Features:
Over 300 OIT graduates!
Articles in Our Research & Learn Center
- Dr. Wasserman interview: OIT...Just the Facts
- Dr. Wasserman: Dallas clinic tries new strategy for dealing with kids’ allergies; The Dallas Morning News, 2015
- Calling all allergists! Dr. Wasserman, PhD and MD, will share his OIT protocol with board-certified allergists
- Dr. Wasserman: Dallas doctors fight fire with fire using experimental desensitizing therapy; Dallas Morning News, 2014
- Dr. Wasserman: Controversial Treatment Ends Food Allergies; NBCDFW TV, NBC affiliate; 2010
- Dr. Wasserman: An OIT pioneer explains why normalizing life is a goal of Private Practice OIT
Map to Office(s)
[property_map1]
[property_map2]
[property_map3]
[property_map4]
[property_map5]
Publications & Presentations
Kamili Q, Seeborg FS, et al Natural Killer cell deficiency and severe cutaneous human papilloma virus infections in post-stem cell transplant of SCID. J Allergy Clin Immunol 2014; 134(6):1451-1453
Kamili Q, Gavino AC, et al. Local reactions during immunotherapy and their impact on dose adjustment. Oral Presentation at the ACAAI Annual Meeting Atlanta, GA; 2014
Kamili Q, Chokshi N, Orange JS et al. Chronic non-iatrogenic lymphatic loss syndromes identified through abnormal TREC analysis from the Texas Newborn Screening Program (NBS). AAAAI Annual Meeting San Diego, CA; 2014.
Lin D, Kamili Q, Lai S, Musher DM, Hamill R. Cereberal Scedosporium apiospermum infection presenting with intestinal manifestations. Infection 2013; 41(3): 723-6.
Javed S, Kamili Q, Tyring SK. Possible association of lower rate of post-herpetic neuralgia in patients on anti-tumor necrosis factor α. J Med Virol 2011; 83 (11): 2051-2055.
Kamili Q, Lu LB, Kolpakchi A. Alexander the Great may have died of this disease. Society of General Internal Medicine Annual Meeting: New Orleans, LA; 2011.
Kamili Q, Shah R, Ross T, Swanson J, Gavino A. Role of early egg ingestion in induction of tolerance: An unanswered question. J Allergy Clin Immunol 2013; 132(6):1454.
Kamili Q, Miner A, Hapa A, Menter A. Infliximab Treatment for Psoriasis in 120 patients on therapy for a minimum of 1 year. J Drugs Dermatol 2011; 10 (5): 539-44.
Kamili Q, Menter A. Atypical Case of Histoplasmosis in a Patient with Psoriasis and Psoriatic Arthritis on Infliximab therapy. J Drugs Dermatol 2010; 9(1): 57-59.
Kamili Q, Menter A. Topical Treatment of Psoriasis: Management of Psoriasis. In: Current Problems in Dermatology. Basel, Karger, 2009; 38: 37-58.
Seroprevalence of Herpes Simplex Virus Type 2 among women attending an antenatal clinic, Post graduate Thesis.
Trends of Tinea capitis in patients attending the Dermatology department of a tertiary health care facility in Kashmir: A 10 month follow up. Wani M, Kamili Qurat ul Ain et al. JK Practitioner 2006; (13) 131-133.
Kamili Q et al. MARQS: Review of J&K Post Graduate Medical Entrance Examination, 1st Edition, 2004
